Brevan Howard Capital Management’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Brevan Howard Capital Management’s Portfolio SILK Stock Details SILK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-23,362	Closed	-$632K	–	1507
2024 Q2	$632K	Sell	23,362 -6,745	-22%	-$140K	0.01%	531
2024 Q1	$552K	Buy	30,107 +11,871	+65%	+$188K	0.01%	427
2023 Q4	$224K	Buy	+18,236	New	+$171K	﹤0.01%	847

Other funds holding SILK

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Brevan Howard Capital Management's SILK Position: Q3 2024 in Review

Brevan Howard Capital Management sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 23,362 shares — an estimated $632K sold.

Brevan Howard Capital Management first reported a position in SILK in Q4 2023 and held it in 3 quarters. The position peaked at $632K in Q2 2024. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

Brevan Howard Capital Management reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
Brevan Howard Capital Management sold 23,362 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $632K.
Brevan Howard Capital Management first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
Brevan Howard Capital Management's Silk Road Medical, Inc. Common Stock position peaked at $632K in Q2 2024.
1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Brevan Howard Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.